bromocriptine has been researched along with Amyotrophic Lateral Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, JE; Iwamoto, K; Iwasaki, Y; Kitagawa, Y; Nagata, E; Ogino, M; Yoshii, F | 1 |
| Hadano, S; Ikeda, JE; Kanno, T; Tanaka, K; Yanagisawa, Y; Yasutake, K; Yoshii, F | 1 |
| Cieślak, D; Klimek, A; Stepień, H; Szulc-Kuberska, J | 1 |
1 trial(s) available for bromocriptine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients.
Topics: Aged; Amyotrophic Lateral Sclerosis; Bromocriptine; Double-Blind Method; Female; Humans; Leukocyte Count; Male; Middle Aged; Riluzole; Treatment Outcome | 2016 |
2 other study(ies) available for bromocriptine and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Bromocriptine; Disease Models, Animal; Disease Progression; Dopamine Agonists; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neuroglia; Neuronal Apoptosis-Inhibitory Protein; Receptors, Dopamine D2; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome; Up-Regulation | 2011 |
Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Bromocriptine; Humans; Hypothalamo-Hypophyseal System; Metoclopramide; Middle Aged; Prolactin; Receptors, Dopamine | 1988 |